 Turning Point Therapeutics Inc NASDAQ: TPTX jumped 110 after announcing a definitive merger agreement with Bristol Myers Squibb Co NYSE: BMY. Under the agreement, Bristol Myers Squibb will acquire Turning Point at 76 per share. 